calendar
8,160 catalysts · 5,811 phase readout · 2,343 8k filing · 426 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,160 catalysts · 5,811 phase readout · 2,343 8k filing · 426 earnings · 3 pdufa · 2 approval · 1 adcom
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 9.01
Items: 4.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 9.01
Items: 5.03, 9.01
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 5.02
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain